U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ENUZOVIMAB
INN  
Official Name English
Enuzovimab [WHO-DD]
Preferred Name English
enuzovimab [INN]
Common Name English
IMMUNOGLOBULIN G4 (226-PROLINE,250-TYROSINE,252-THREONINE,254-GLUTAMIC ACID), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL HFB30132A .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL H
Common Name English
Code System Code Type Description
FDA UNII
D474BW0A5E
Created by admin on Wed Apr 02 07:25:32 GMT 2025 , Edited by admin on Wed Apr 02 07:25:32 GMT 2025
PRIMARY
INN
12009
Created by admin on Wed Apr 02 07:25:32 GMT 2025 , Edited by admin on Wed Apr 02 07:25:32 GMT 2025
PRIMARY
NCI_THESAURUS
C182100
Created by admin on Wed Apr 02 07:25:32 GMT 2025 , Edited by admin on Wed Apr 02 07:25:32 GMT 2025
PRIMARY
CAS
2531098-91-4
Created by admin on Wed Apr 02 07:25:32 GMT 2025 , Edited by admin on Wed Apr 02 07:25:32 GMT 2025
PRIMARY
SMS_ID
300000041912
Created by admin on Wed Apr 02 07:25:32 GMT 2025 , Edited by admin on Wed Apr 02 07:25:32 GMT 2025
PRIMARY
ACTIVE MOIETY
ENUZOVIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966